SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-24-000051
Filing Date
2024-08-30
Accepted
2024-08-30 16:14:13
Documents
13
Period of Report
2024-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K amph-20240828x8k.htm   iXBRL 8-K 54010
  Complete submission text file 0001297184-24-000051.txt   174602

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20240828.xsd EX-101.SCH 3498
3 EX-101.LAB amph-20240828_lab.xml EX-101.LAB 15361
4 EX-101.PRE amph-20240828_pre.xml EX-101.PRE 10385
15 EXTRACTED XBRL INSTANCE DOCUMENT amph-20240828x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 241270207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)